|
Richard L. Anderson. Richard L. Anderson has served as a director of the Company since the consummation of the Merger on June 5, 2007. Mr. Anderson has served as the Corporate Vice President and Chief Financial Officer of Mannkind Corporation, a biopharmaceutical company, since October 2002. From January 1997 to September 2002, Mr. Anderson held various executive positions at NeoRx Corporation, a Seattle-based publicly traded biotechnology company, including President, Chief Operating Officer, Chief Financial Officer and Senior Vice President, Finance and Operations. Mr. Anderson holds a master’s degree in Management from Johns Hopkins University, a master’s degree in solid state physics from the University of Maryland and a bachelor’s degree in physics from Bucknell University. Mr. Anderson is a member of the American Institute of Certified Public Accountants | 